ReviewCurrent research in microbial sciences2026
Omics-based dissection of alternative splicing and the regulatory architecture in fungal genomes.
Review in Current research in microbial sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Assigning mechanistic and functional associations to most of the widespread splicing diversity in fungi has been one of the continuous and most intriguing challenges in the field of molecular mycology. Ongoing advances in sequencing technologies have driven recent outbreaks in the study of the dynamic splicing landscapes of fungal transcriptomes. Nevertheless, most ascomycete and basidiomycete species of agronomic, industrial, and medical interest exhibit a notable proportion of their transcripts affected by alternative splicing (AS), producing mRNA isoforms whose regulation and functions have been largely ignored to date. In contrast to all other fungi, some yeast and basal fungal clades exhibit extremely scarce AS occurrences, which are associated with very low genomic intron counts. In this review, we provide thoughtful insights into three long-standing unsolved questions: (1) the pervasive occurrence and possible stochasticity of intron retention in fungi, (2) the reasons for increased AS rates in pathogenic and filamentous species, and (3) possible hypotheses to explain the functionality and fitness advantages of AS in fungi. We present a critical discussion on the role of AS, highlighting its importance in an evolutionary context that integrates major features of fungal diversification and adaptability. To advance our understanding of fungal splicing control, function, and evolution, we propose a practical roadmap for future research, aimed at filling the most critical gaps in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.